Clinical Trial Detail

NCT ID NCT02204020
Title Phase II Study of 5-azacytidine Maintenance After Transplant for AML or MDS
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Pittsburgh
Indications

acute myeloid leukemia

Therapies

Azacitidine

Age Groups: adult

No variant requirements are available.